News | March 5, 2024

Lab Community ‘Extremely Concerned' About Patient Access To Testing If FDA Regulates Lab-Developed Tests

Salt Lake City, UT /PRNewswire/ - Nearly 85% of respondents to an ARUP Laboratories survey on the impact of the FDA's proposed rule to regulate laboratory-developed tests (LDTs) believe the proposal will hurt their laboratories and, ultimately, patient care. Most respondents were either "extremely concerned" or "very concerned" about the impact of the proposed rule on patient access to essential testing and innovation, the financial and personnel resources required to comply, and the FDA's ability to implement the proposed rule.

Source: ARUP Laboratories

Copyright 2024 PR Newswire. All Rights Reserved